Celldex Therapeutics reported $1.88B in Market Capitalization this November of 2026, considering the latest stock price and the number of outstanding shares.





Market Capitalization Change Date
AbbVie USD 508.97B 46.71B Nov/2026
Agenus USD 128M 21M Mar/2026
Amgen USD 247.94B 20.06B Nov/2026
Bristol-Myers Squibb USD 127.46B 9.81B Sep/2026
Celldex Therapeutics USD 1.88B 669M Nov/2026
Glaxosmithkline GBP 101.7B 4.58B Nov/2026
Nektar Therapeutics USD 2.12B 1.26B Mar/2026
Northwest Biotherapeutics USD 332M 24M Mar/2026
Pfizer USD 169.88B 6.47B Nov/2026
Roche Holding CHF 270B 3.66B Jun/2026